Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

National Advertising Division Conference In Brief

This article was originally published in The Tan Sheet

Executive Summary

The National Advertising Division, a self-regulatory agency that reviews advertising claims, administered by the Council of Better Business Bureaus, held its annual conference Oct. 4 and 5 in New York City. The event, "What's New in Comparative Advertising, Claim Support and Self-Regulation," covered claim substantiation for all types of products at all levels of government and within NAD

You may also be interested in...



Burt's Defends "Clinically Proven" Toothpaste Claim Against Tom's Challenge

The National Advertising Division determined Burt's Bees supports claims its Natural Toothpaste line is "clinically proven," but recommended the Clorox brand modify claims about cranberry extract benefits.

Burt's Defends "Clinically Proven" Toothpaste Claim Against Tom's Challenge

The National Advertising Division determined Burt's Bees supports claims its Natural Toothpaste line is "clinically proven," but recommended the Clorox brand modify claims about cranberry extract benefits.

Burt's Defends "Clinically Proven" Toothpaste Claim Against Tom's Challenge

The National Advertising Division determined Burt's Bees supports claims its Natural Toothpaste line is "clinically proven," but recommended the Clorox brand modify claims about cranberry extract benefits.

Related Content

Topics

Latest News
See All
UsernamePublicRestriction

Register

PS104587

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel